Please confirm you are human (Sign Up for free to never see this)
← Back to Search
Targeted Inhibition Of Amyloidogenesis Using A Non-toxic, Serum Stable Strategically Designed Cyclic Peptide With Therapeutic Implications.
Ranit Pariary, Baijayanti Ghosh, Z. Bednaříková, Kyriakos G Varnava, B. N. Ratha, S. Raha, Dipita Bhattacharyya, Z. Gazova, V. Sarojini, Atin K. Mandal, A. Bhunia
Published 2020 · Chemistry, Medicine
Save to my Library
Download PDFAnalyze on Scholarcy
Amyloidogenic disorders are currently rising as a global health issue, prompting more and more studies dedicated to the development of effective targeted therapeutics. The innate affinity of these amyloidogenic proteins towards the biomembranes adds further complexities to the systems. Our previous studies have shown that biologically active peptides can effectively target amyloidogenesis serving as an efficient therapeutic alternative in several amyloidogenic disorders. The structural uniqueness of the PWWP motif in the de novo designed heptapeptide, KR7 (KPWWPRR-NH2) was demonstrated to target insulin fiber elongation specifically. By working on Insulin, an important model system in amyloidogenic studies, we gained several mechanistic insights into the inhibitory actions at the protein-peptide interface. Here, we report a second-generation non-toxic and serum stable cyclic peptide, based primarily on the PWWP motif that resulted in complete inhibition of insulin fibrillation both in the presence and absence of the model membranes. Using both low- and high-resolution spectroscopic techniques, we could delineate the specific mechanism of inhibition, at atomistic resolution. Our studies put forward an effective therapeutic intervention that redirects the default aggregation kinetics towards off-pathway fibrillation. Based on the promising results, this novel cyclic peptide can be considered an excellent lead to design pharmaceutical molecules against amyloidogenesis.
This paper references
Biphasic effects of insulin on islet amyloid polypeptide membrane disruption.
J. Brender (2011)
Localized cutaneous amyloid at an insulin injection site
A. A. Lonsdale-Eccles (2009)
Partially folded intermediates in insulin fibrillation.
A. Ahmad (2003)
Bovine insulin filaments induced by reducing disulfide bonds show a different morphology, secondary structure, and cell toxicity from intact insulin amyloid fibrils.
T. Zako (2009)
Insulin assembly damps conformational fluctuations: Raman analysis of amide I linewidths in native states and fibrils.
Jian Dong (2003)
Localized insulin amyloidosis with use of concentrated insulin: a potential complication
A. Mangla (2016)
A review of biodegradable polymeric systems for oral insulin delivery
Y. Luo (2016)
Pore Formation by the Cytotoxic Islet Amyloid Peptide Amylin (*)
T. Mirzabekov (1996)
Intra- and extracellular amyloid fibrils are formed in cultured pancreatic islets of transgenic mice expressing human islet amyloid polypeptide.
E. D. de Koning (1994)
Inhibition of Insulin Amyloid Fibrillation by a Novel Amphipathic Heptapeptide
B. N. Ratha (2016)
The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles.
J. Janson (1999)
Use of a Small Peptide Fragment as an Inhibitor of Insulin Fibrillation Process: A Study by High and Low Resolution Spectroscopy
V. Banerjee (2013)
The aggregation potential of human amylin determines its cytotoxicity towards islet β‐cells
B. Konarkowska (2006)
Protein folding and misfolding
C. Dobson (2003)
The insulin ball
T. Nagase (2009)
Neutral Insulin Solutions Physically Stabilized by Addition of Zn2+
J. Brange (1986)
Mechanism of Insulin Fibrillation
Q. Hua (2004)
ISLET AMYLOID FORMED FROM DIABETES-ASSOCIATED PEPTIDE MAY BE PATHOGENIC IN TYPE-2 DIABETES
A. Clark (1987)
Insulin Administration via Liposomes
R. S. Spangler (1990)
The effects of various membrane physical-chemical properties on the aggregation kinetics of insulin.
Stefan Grudzielanek (2007)
Pharmaceutical amyloidosis associated with subcutaneous insulin and enfuvirtide administration
A. D’Souza (2014)
Oligomerization of Peptides LVEALYL and RGFFYT and Their Binding Affinity to Insulin
Hsin-Lin Chiang (2013)
Membrane interactions of two arginine-rich peptides with different cell internalization capacities.
A. Walrant (2012)
Molecular mechanism of Thioflavin-T binding to amyloid fibrils.
Matthew Biancalana (2010)
Toward the solution structure of human insulin: sequential 2D 1H NMR assignment of a des-pentapeptide analogue and comparison with crystal structure.
Q. Hua (1990)
Nanoparticle based insulin delivery system: the next generation efficient therapy for Type 1 diabetes
G. Sharma (2015)
Cholesterol facilitates interactions between α‐synuclein oligomers and charge‐neutral membranes
Andreas van Maarschalkerweerd (2015)
Solid-phase peptide synthesis: from standard procedures to the synthesis of difficult sequences
Irene Coin (2007)
Microneedles: an emerging transdermal drug delivery system
Shital H. Bariya (2012)
Toxicity of insulin-derived amyloidosis: a case report
K. Iwaya (2019)
Amyloid beta-protein interactions with membranes and cholesterol: causes or casualties of Alzheimer's disease.
W. Gibson Wood (2003)
Recent advances in the oral delivery of insulin.
Rekha M Ramesan (2014)
Sequence specificity of amylin-insulin interaction: a fragment-based insulin fibrillation inhibition study.
B. N. Ratha (2019)
Modulation of pathway of insulin fibrillation by a small molecule helix inducer 2,2,2-trifluoroethanol.
V. Banerjee (2012)
Model membrane size-dependent amyloidogenesis of Alzheimer's amyloid-β peptides.
Misaki Kinoshita (2017)
Insulin-eukaryotic model membrane interaction: Mechanistic insight of insulin fibrillation and membrane disruption.
B. N. Ratha (2018)
Membrane damage by human islet amyloid polypeptide through fibril growth at the membrane
Maarten F. M. Engel (2008)
Protein misfolding, evolution and disease.
C. Dobson (1999)
Human recombinant insulin and amyloidosis: an unexpected association.
M. P. Sie (2010)
Serum stability of peptides.
H. Jenssen (2008)
Mechanistic Studies of the Inhibition of Insulin Fibril Formation by Rosmarinic Acid.
Qiuchen Zheng (2018)
Group epitope mapping by saturation transfer difference NMR to identify segments of a ligand in direct contact with a protein receptor.
M. Mayer (2001)
Characterization of Ligand Binding by Saturation Transfer Difference NMR Spectroscopy.
M. Mayer (1999)
Membrane disordering is not sufficient for membrane permeabilization by islet amyloid polypeptide: studies of IAPP(20-29) fragments.
J. Brender (2013)
Y. Gupta (2015)
Comparative 2D NMR studies of human insulin and des-pentapeptide insulin: sequential resonance assignment and implications for protein dynamics and receptor recognition.
Q. Hua (1991)
Inhibition of insulin fibrillation by osmolytes: Mechanistic Insights
Sinjan Choudhary (2015)
Three-dimensional solution structure of an insulin dimer. A study of the B9(Asp) mutant of human insulin using nuclear magnetic resonance, distance geometry and restrained molecular dynamics.
A. M. Jørgensen (1992)
Structural Insight of Amyloidogenic Intermediates of Human Insulin
Sandip Dolui (2018)
Localized amyloidosis at the site of repeated insulin injection in a diabetic patient.
Y. Shikama (2010)
Cyclic Peptides as Therapeutic Agents and Biochemical Tools
S. Joo (2012)
Enhancing the Cell Permeability and Metabolic Stability of Peptidyl Drugs by Reversible Bicyclization.
Ziqing Qian (2017)
Amyloid fibrillation and cytotoxicity of insulin are inhibited by the amphiphilic surfactants.
S. S. Wang (2010)
Localized insulin‐derived amyloidosis: A potential pitfall in the diagnosis of systemic amyloidosis by fat aspirate
A. D’Souza (2012)
The synthesis of cystine peptides by iodine oxidation of s trityl cysteine and s acetamidomethyl cysteine peptides
B. Kamber (1980)
A single mutation in the nonamyloidogenic region of islet amyloid polypeptide greatly reduces toxicity.
J. Brender (2008)
Islet Amyloid Polypeptide Membrane Interactions: Effects of Membrane Composition.
Xiaoxue Zhang (2017)
Applications of saturation transfer difference NMR in biological systems.
A. Bhunia (2012)
Fluorescent silicon nanoparticles inhibit the amyloid fibrillation of insulin.
Yingying Ma (2019)
Conformational Dynamics of Insulin
Q. Hua (2011)
The structural basis of protein folding and its links with human disease.
C. Dobson (2001)
This paper is referenced by
Mechanistic Studies of the Stabilization of Insulin Helical Structure by Coomassie Brilliant Blue
Sandip Dolui (2020)